Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,580.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,314.0,1.0,=,1.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1454.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,353.0,1.0,=,4.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1582.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,987.0,1.0,=,1.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2180.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,602.0,1.0,=,3.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2340.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,466.0,1.0,=,5.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2881.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,1012.0,1.0,=,2.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3943.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,1349.0,1.0,=,2.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,608.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,527.0,1.0,=,1.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,625.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,307.0,1.0,=,2.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,893.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,318.0,1.0,=,2.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,912.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,637.0,1.0,=,1.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1177.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,450.0,1.0,=,2.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1190.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,350.0,1.0,=,3.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1309.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,665.0,1.0,=,2.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1357.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,374.0,1.0,=,3.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,580.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,343.0,1.0,=,1.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1454.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,509.0,1.0,=,2.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1582.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,991.0,1.0,=,1.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2180.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,711.0,1.0,=,3.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2340.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,665.0,1.0,=,3.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2881.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,1402.0,1.0,=,2.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3943.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,1457.0,1.0,=,2.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,608.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,605.0,1.0,=,1.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,625.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,316.0,1.0,=,2.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,893.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,433.0,1.0,=,2.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,912.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,616.0,1.0,=,1.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1177.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,517.0,1.0,=,2.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1190.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,440.0,1.0,=,2.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1309.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,1117.0,1.0,=,1.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1357.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,598.0,1.0,=,2.3